HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial-Reference-Cited by-同舟云学术

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

Published:2009-05-15 Issue:8 Volume:23 Page:929-939
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Calmy Alexandra,Gayet-Ageron Angèle,Montecucco Fabrizio,Nguyen Alain,Mach Francois,Burger Fabienne,Ubolyam Sasiwimol,Carr Andrew,Ruxungtham Kiat,Hirschel Bernard,Ananworanich Jintanat

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference46 articles.

1. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study;Ledergerber;Lancet,1999

2. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study;Palella;J Acquir Immune Defic Syndr,2006

3. Changes in causes of death among adults infected by HIV between 2000 and 2005: the ‘Mortalité 2000 and 2005’ surveys (ANRS EN 19 and Mortavic);Lewden;J Acquir Immune Defic Syndr,2008

4. Class of antiretroviral drugs and the risk of myocardial infarction;Friis-Moller;N Engl J Med,2007

5. HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy;Sterne;J Intern Med,2007

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asociación entre la inflamación cardiovascular y los cambios del sistema inmune inducidos por la infección por VIH mediante PET/RM con [18F]FDG;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

2. Association between cardiovascular inflammation and alterations in immune system induced by HIV infection detected on [18F]FDG PET/MRI;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-09

3. Endothelial dysfunction and cardiovascular diseases in people living with HIV on specific highly active antiretroviral therapy regimen: A systematic review of clinical studies;Atherosclerosis Plus;2024-03

4. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis;BMC Infectious Diseases;2024-02-02

5. Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review;Cardiology in Review;2024-01-31